Differences in gene expression may contribute to the racial differences in the risk of MASLD.

Abstract excerpt

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), exhibits marked racial disparities in incidence, progression, and clinical outcomes. While diet, lifestyle, and socioeconomic factors have been shown to influence these disparities, biological mechanisms underlying racial differences in MASLD risk remain poorly understood. We hypothesized...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Black or African American
• Share to Disease Progression
• Share to Gene Expression Profiling